Clinicians may have difficulty in making a diagnosis. Various macular dystrophies can resemble AMD due to the variety of clinical signs and symptoms. Clinicians may find it challenging to ...
This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.
Under the terms of the agreement, Iolyx Therapeutics has granted Théa exclusive worldwide development and commercialization rights, excluding Asia, to ILYX-002 for the treatment of ocular surface ...
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host ...
Amanda Nanasy, OD, discussed how sports can open the door to eye care for underserved athletes and what goes into her ...
The licaminlimab trial enrolled 176 patients, two-thirds with a TNFR1 variant tied to stronger response. Data expected late 2026.
FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites. The FDA granted ...
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results